Theravance Biopharma Inc. (TBPH) Declined -5.46% or -0.92 To Price $15.85 On Friday

Theravance Biopharma Inc. (TBPH) declined -5.46% or -0.92 to $15.85. It is about 229805 shares traded, which is 66.21% compare to the average total volume 347110. The market cap of TBPH is $889.49 million. The year to date change is -41.44%. The 52 week price range is from $15.18 to $35.48. Price of TBPH have changed 4.36% during last week. It have changed -21.77% over last month, -32.17% over last 3 months, -39.90% over last 6 months and -31.68% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TBPH is 21.14. It is 33.38% above current price. The 200-day Moving Averages for TBPH is 25.27. It is 59.43% above current price. The 52-week High is 35.48. It is 123.85% from the current price. The 52-week Low is 15.18. It is -4.23% from current price.

There are some statistics of TBPH. It is has market cap $889.49 million. The share outstanding is 56.14 million. The average volume is 347110. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TBPH is 803.72%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TBPH is -46.05%.


Share this post